← Insiders

CURI

Neutral signal

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

ACHAT TOTAL: 50 000 titres (~128 650,00 $ US)

Insiders
Stinchcomb Clinton Larry
Total bought
$128,650

Avg buy (VWAP, 90d window) $2.57 vs last close —

Total sold
—

Avg sell (VWAP, 90d window) —

Last activity
2026-08-28
Last synced
2026-09-03 09:53:14 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-08-28 Stinchcomb Clinton Larry Buy 20,000 $2.60 $52,060 Form 4
2026-08-27 Stinchcomb Clinton Larry Buy 30,000 $2.55 $76,590 Form 4

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

Market snapshot

Signal

Neutral signalScored 2026-09-02

CURI presents a compelling post-earnings catalyst with record EBITDA, 22% revenue growth, a 40% stock surge, and strong institutional conviction (Zacks Strong Buy, insider buying), supporting a high catalyst score of 75…

The first sentence of the analysis written for CURI on 2026-09-02 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin56.6%50.4%37.5%34.0%48.5%
Ebit Margin-8.9%-25.0%-85.1%-64.8%-52.3%
Ebitda Margin11.5%13.0%-43.9%-13.5%-12.3%
Operating Profit Margin-10.2%-26.1%-44.8%-66.2%-73.6%
Pretax Profit Margin-8.9%-25.0%-85.1%-64.8%-52.3%
Continuous Operations Profit Margin-9.0%-25.3%-85.9%-65.2%-52.8%
Net Profit Margin-9.0%-25.3%-85.9%-65.2%-52.8%
Bottom Line Profit Margin-9.0%-25.3%-85.9%-65.2%-74.1%
Current Ratio1.2351.6561.9362.2452.362
Quick Ratio1.2351.6561.9362.2452.362
Solvency Ratio0.2410.230-0.898-0.299-0.164
Cash Ratio0.6040.3281.6121.2920.317
Price To Earnings Ratio-34.545-6.375-0.587-1.188-8.123
Price To Earnings Growth Ratio0.6380.0860.141-0.0380.393
Forward Price To Earnings Growth Ratio0.6380.0860.141-0.0380.393
Price To Earnings Diluted Ratio-34.545-6.375-0.587-1.188-8.123
Price To Earnings Diluted Growth Ratio0.6380.0860.141-0.0380.393
Price To Book Ratio5.2821.4410.3940.5121.885
Price To Sales Ratio3.0581.6300.5040.7714.284
Price To Free Cash Flow Ratio16.91410.226-1.771-1.518-4.148
Price To Operating Cash Flow Ratio16.78210.226-1.772-1.523-4.168
Debt To Assets Ratio0.0510.0500.0420.0300.000
Debt To Equity Ratio0.0940.0740.0590.0400.000
Debt To Capital Ratio0.0860.0690.0560.0380.000
Long Term Debt To Capital Ratio0.0770.0000.0000.0000.000
Financial Leverage Ratio1.8251.4901.3911.3101.344
Working Capital Turnover Ratio6.2922.7241.8821.5031.502
Operating Cash Flow Ratio0.4310.342-0.691-1.277-1.527
Operating Cash Flow Sales Ratio0.1820.159-0.284-0.506-1.028
Free Cash Flow Operating Cash Flow Ratio0.9921.0001.0001.0031.005
Debt Service Coverage Ratio0.0000.0000.0000.0000.000
Interest Coverage Ratio0.0000.0000.0000.0000.000
Short Term Operating Cash Flow Coverage Ratio0.0000.0000.0000.0000.000
Operating Cash Flow Coverage Ratio3.3581.903-3.776-8.5030.000
Capital Expenditure Coverage Ratio128.0100.000-3,234.400-304.023-208.667
Dividend Paid And Capex Coverage Ratio0.5902.006-3,234.400-304.023-208.667
Dividend Payout Ratio-3.425-0.3140.0000.0000.000
Enterprise Value Multiple24.77511.9840.191-2.350-33.030

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 56.6% ▲6.2% ▲11.2%
Ebit Margin -8.9% ▲16.1% ▲38.3%
Ebitda Margin 11.5% ▼-1.5% ▲20.6%
Operating Profit Margin -10.2% ▲15.9% ▲34.0%
Pretax Profit Margin -8.9% ▲16.1% ▲38.3%
Continuous Operations Profit Margin -9.0% ▲16.3% ▲38.7%
Net Profit Margin -9.0% ▲16.3% ▲38.7%
Bottom Line Profit Margin -9.0% ▲16.3% ▲43.0%
Current Ratio 1.235 ▼-0.421 ▼-0.652
Quick Ratio 1.235 ▼-0.421 ▼-0.652
Solvency Ratio 0.241 ▲0.011 ▲0.419
Cash Ratio 0.604 ▲0.276 ▼-0.226
Price To Earnings Ratio -34.545 ▼-28.171 ▼-24.382
Price To Earnings Growth Ratio 0.638 ▲0.551 ▲0.394
Forward Price To Earnings Growth Ratio 0.638 ▲0.551 ▲0.394
Price To Earnings Diluted Ratio -34.545 ▼-28.171 ▼-24.382
Price To Earnings Diluted Growth Ratio 0.638 ▲0.551 ▲0.394
Price To Book Ratio 5.282 ▲3.841 ▲3.379
Price To Sales Ratio 3.058 ▲1.428 ▲1.008
Price To Free Cash Flow Ratio 16.914 ▲6.688 ▲12.973
Price To Operating Cash Flow Ratio 16.782 ▲6.556 ▲12.873
Debt To Assets Ratio 0.051 ▲0.002 ▲0.017
Debt To Equity Ratio 0.094 ▲0.020 ▲0.041
Debt To Capital Ratio 0.086 ▲0.017 ▲0.036
Long Term Debt To Capital Ratio 0.077 ▲0.077 ▲0.062
Financial Leverage Ratio 1.825 ▲0.336 ▲0.353
Working Capital Turnover Ratio 6.292 ▲3.569 ▲3.512
Operating Cash Flow Ratio 0.431 ▲0.089 ▲0.975
Operating Cash Flow Sales Ratio 0.182 ▲0.023 ▲0.478
Free Cash Flow Operating Cash Flow Ratio 0.992 ▼-0.008 ▼-0.008
Debt Service Coverage Ratio 0.000 0.000 0.000
Interest Coverage Ratio 0.000 0.000 0.000
Short Term Operating Cash Flow Coverage Ratio 0.000 0.000 0.000
Operating Cash Flow Coverage Ratio 3.358 ▲1.455 ▲4.762
Capital Expenditure Coverage Ratio 128.010 ▲128.010 ▲851.826
Dividend Paid And Capex Coverage Ratio 0.591 ▼-1.416 ▲749.489
Dividend Payout Ratio -3.425 ▼-3.111 ▼-2.677
Enterprise Value Multiple 24.775 ▲12.792 ▲24.461

Key metrics

MetricTrend20252024202320222021
Market cap$219.1M$83.4M$28.6M$60.2M$305.3M
Enterprise value$204.7M$79.8M-$4.8M$24.8M$290.1M
EV / Sales2.86x1.56x-0.08x0.32x4.07x
EV / Op. cash flow15.68x9.79x0.30x-0.63x-3.96x
EV / Free cash flow15.80x9.79x0.30x-0.63x-3.94x
EV / EBITDA24.77x11.98x0.19x-2.35x-33.03x
Net debt / EBITDA-1.75x-0.53x1.34x3.35x1.73x
Current ratio1.24x1.66x1.94x2.25x2.36x
Income quality-2.03x-0.63x0.33x0.78x1.95x
Graham net-net-$0$0$0$1$1
Tax burden100.2%101.0%101.0%100.7%101.0%
Interest burden100.0%100.0%100.0%100.0%100.0%
Working capital$7.1M$15.7M$21.9M$38.5M$65.3M
Invested capital$10.3M$50.8M$70.9M$111.8M$143.5M
Return on assets-8.5%-15.0%-48.4%-33.0%-17.3%
Operating ROA-9.0%-14.2%-20.0%-27.8%-34.3%
Return on tangible assets-8.5%-23.7%-87.2%-59.5%-26.7%
Return on equity-15.5%-22.4%-67.3%-43.3%-23.2%
Return on invested capital-15.9%-21.3%-32.9%-42.0%-30.9%
Return on capital employed-16.1%-21.4%-32.9%-42.0%-30.9%
Earnings yield-2.9%-15.5%-170.7%-84.6%-12.3%
Free cash flow yield5.9%9.8%-56.5%-65.9%-24.1%
Capex / Op. cash flow0.8%0.0%-0.0%-0.3%-0.5%
Capex / Depreciation0.7%0.0%0.0%0.3%1.2%
Capex / Sales0.1%0.0%0.0%0.2%0.5%
SG&A / Sales66.8%76.5%82.3%100.2%122.2%
R&D / Sales0.0%0.0%0.0%0.0%0.0%
Stock comp / Sales20.0%12.8%7.0%8.5%9.8%
Intangibles / Total assets0.0%36.6%44.5%44.4%35.3%
Days sales outstanding45d44d31d51d120d
Days payables outstanding111d81d49d43d34d
Operating cycle45d44d31d51d120d
Cash conversion cycle-66d-37d-18d8d86d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▲+162.9%EV / Sales ▲+83.0%EV / EBITDA ▲+106.7%EV / Op. cash flow ▲+5.885Earnings yield ▲+0.126
Profitability
Return on equity ▲+0.069Return on assets ▲+0.065Return on invested capital ▲+0.053Return on capital employed ▲+0.053Operating ROA ▲+0.052Income quality ▼-1.402Tax burden ▼-0.008
Efficiency
Days sales outstanding ▲+1.734Days payables outstanding ▲+30.145Operating cycle ▲+1.734Cash conversion cycle ▼-28.411Capex / Sales n/aR&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.421Net debt / EBITDA ▼-1.215Working capital ▼-8534000.000Invested capital ▼-40463000.000Intangibles / Total assets ▼-0.366

Change over 5 years

Valuation
Market cap ▼-28.2%EV / Sales ▼-29.8%EV / EBITDA ▲+175.0%EV / Op. cash flow ▲+19.637Earnings yield ▲+0.094
Profitability
Return on equity ▲+0.077Return on assets ▲+0.088Return on invested capital ▲+0.150Return on capital employed ▲+0.149Operating ROA ▲+0.253Income quality ▼-3.978Tax burden ▼-0.007
Efficiency
Days sales outstanding ▼-75.034Days payables outstanding ▲+76.732Operating cycle ▼-75.034Cash conversion cycle ▼-151.766Capex / Sales ▼-0.004R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-1.127Net debt / EBITDA ▼-3.479Working capital ▼-58194000.000Invested capital ▼-133213000.000Intangibles / Total assets ▼-0.353

Employee count

Peer market caps

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent news